Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
ACRP, adjunct, Advent, Advisor, Anika, Ann, Arix, back, Baxter, Baylor, Becton, Biochemistry, Biogen, biology, biomedical, Bioscience, Biotech, Blvd, Bobae, Bochum, Brown, Bruder, Caltech, Candela, Cantor, career, CCRA, Chair, chaired, chairman, Chamber, Charitable, clarify, Cloyd, Commerce, Crispin, cum, customary, Del, Delta, Deposit, Dickinson, DNA, Ekso, entrepreneurial, exoskeleton, faculty, FDIC, forfeiture, Foundation, founder, Fresh, fruit, Fudan, Geffen, Genzyme, German, Germany, Goldman, graduate, Idec, Imperial, inflation, Iowa, Johnson, Kellogg, Kim, laude, Lincare, London, lt, Macau, magna, mainland, managerial, Mary, McMaster, mentoring, Ministry, Minnesota, Monte, multinational, mutual, NCMIC, Nephew, Northwestern, Orthopedic, Pakistan, Playhouse, power, powered, Professor, pronouncement, PwC, RAC, recipient, regenerative, reimposed, Royal, Ruhr, Scott, Silicon, simultaneously, Smith, spinal, Stryker, subscription, Subtopic, summa, surgical, SVB, Teufel, Tracon, UCLA, unblinded, underwriter, unexercised, unrestricted, usage, vacate, Valley, Viewray, Western, Women, Xeotron
Filing tables
Filing exhibits
Related press release
BLPH similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-232002, 333-230256, 333-225871, 333-219387, 333-210312, 333-202069, and 333-257007) on Form S-8, the registration statements (Nos. 333-239473, 333-225878, 333-221087 and 333-211166) on Form S-3 and the registration statements (Nos. 333-214773 and 333-214230) on Form S-1 of our report dated March 31, 2023, with respect to the consolidated financial statements of Bellerophon Therapeutics, Inc.
/s/ KPMG LLP
Short Hills, New Jersey
March 31, 2023